Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemoch...
FDA Device Recall #Z-0880-2026 - Class II, November 5, 2025
Recall Summary
| Recall Number | Z-0880-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | November 5, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Accriva Diagnostics, Inc. |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 20250 |
Product Description
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System
Reason for Recall
Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.
Distribution Pattern
Worldwide - US Nationwide distribution including in the states of OH, IL, NY, GA, CA, IN, NJ, TX, KS, NE, FL, SC, MO, WV, WA, MI, CO, TN, PA, UT, LA, MT, NC, KY, TX and the countries of CA.
Lot / Code Information
UDI-DI: 10711234103081. Lot: E5JLR132. Expiration: 08-31-2026
Other Recalls from Accriva Diagnostics, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2460-2026 | Class II | directCHECK ACT-LR whole blood quality control,... | Apr 30, 2026 |
| Z-0500-2026 | Class III | VerifyNow PRUTest Platelet Reactivity Test REF ... | Oct 21, 2025 |
| Z-0961-2025 | Class II | VerifyNow P2Y12 Platelet Reactivity Test, REF: ... | Dec 2, 2024 |
| Z-0279-2025 | Class II | AVOXimeter 1000E, Product Number: AVOX1000E. Th... | Sep 27, 2024 |
| Z-1121-2022 | Class II | The VerifyNow P2Y12 Test is designed to measure... | Mar 30, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.